{"doi":"10.1016/j.pcad.2016.07.011","title":"Nonstatins and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Role in Non‐Familial Hypercholesterolemia","abstract":null,"journal":"Progress in Cardiovascular Diseases","year":2016,"id":28890,"datarank":1.0317987752584328,"base_score":2.70805020110221,"endowment":2.70805020110221,"self_citation_contribution":0.40620753016533157,"citation_network_contribution":0.6255912450931013,"self_endowment_contribution":0.40620753016533157,"citer_contribution":0.6255912450931013,"corpus_percentile":null,"corpus_rank":null,"citation_count":14,"citer_count":13,"citers_with_citation_signal":11,"citers_with_endowment":11,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":71310,"name":"Jennifer G. Robinson","orcid":"0000-0002-4432-4352","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":2.70805020110221,"endowment":2.70805020110221,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"27498088","pmcid":null,"openalex_id":"https://openalex.org/W2503132713","authors":[],"funders":[],"total_grants":0,"fwci":2.8118,"citation_percentile":0.90150242,"influential_citations":0,"citation_trend":[{"year":2016,"count":1},{"year":2017,"count":3},{"year":2018,"count":3},{"year":2019,"count":2},{"year":2020,"count":2},{"year":2024,"count":1},{"year":2025,"count":2}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0033062016300755?httpAccept=text/plain","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0033062016300755?httpAccept=text/xml","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.pcad.2016.07.011","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/27498088","host_type":"repository"}],"fields_of_study":["Lipoproteins and Cardiovascular Health","Computational Drug Discovery Methods","Vitamin K Research Studies","Medicine","Anticholesteremic Agents","Cardiovascular Diseases","Clinical Decision-Making","Ezetimibe","Humans","Hypercholesterolemia","Medication Therapy Management","PCSK9 Inhibitors","Proprotein Convertase 9"],"mesh_terms":["Clinical Decision-Making","Ezetimibe","Proprotein Convertase 9","PCSK9 Inhibitors","Anticholesteremic Agents","Cardiovascular Diseases","Humans","Hypercholesterolemia","Medication Therapy Management"],"keywords":["Kexin","PCSK9","Proprotein convertase","Medicine","Subtilisin","Familial hypercholesterolemia","Proprotein Convertases","Pharmacology","LDL receptor","Internal medicine","Cholesterol","Lipoprotein","Biochemistry","Enzyme","Ezetimibe","Risk Reduction","Pcsk9 Inhibitor"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Peace, Justice and strong institutions"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T22:18:44.483351Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}